How a New Oral Antiviral Pill Stops Airborne Virus Outbreaks Before They Spread
The publication of definitive Phase 3 trial data in the New England Journal of Medicine marked a fundamental shift in how public health institutions counter airborne viral threats. Results from the global SCORPIO-PEP study demonstrated that a five-day course of the investigational drug ensitrelvir ...